# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA623778 | A | Pharmacokinetic property when administered intravenously in rat at 2 mg/kg | Rattus norvegicus | 11 | organism-based format | Scientific Literature | ||
2. | ALA626081 | A | Half life period was evaluated in rat plasma | Rattus norvegicus | 12 | organism-based format | Scientific Literature | ||
3. | ALA657022 | F | In vitro antifungal activity against Candida albicans (CY1002) in 80% calf serum | Candida albicans | 12 | organism-based format | Scientific Literature | ||
4. | ALA657024 | F | In vitro antifungal activity against Candida albicans (CY1002) in YNBPB medium in rat | Candida albicans | 1 | organism-based format | Scientific Literature | ||
5. | ALA872440 | B | In vitro inhibitory activity against aspergillus fumigatus Nmt (AfNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM) | Aspergillus fumigatus | 1 | protein format | Scientific Literature | ||
6. | ALA750523 | B | In vitro inhibitory activity against candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM) | Candida albicans | 1 | protein format | Scientific Literature | ||
7. | ALA748917 | B | In vitro inhibitory activity against human Nmt (HsNmt) using 0.5 uM peptide GNAASAR-R-NH2 and 0.5 uM myristoyl-CoA | Homo sapiens | 11 | protein format | Scientific Literature | ||
8. | ALA785471 | F | Antifungal activity determined in rat infected with Candida albicans CY1002. | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
9. | ALA925057 | B | Inhibition of Candida albicans N-myristoyltransferse | Candida albicans | 47 | single protein format | Scientific Literature |